Neuraxis, Inc.
Symbol: NRXS (NYSE)
2.41
▼ (-2.32%) -0.057
Company Description:
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Key Stats
- Today's Open: $2.455
- Today's High: $2.49
- Today's Low: $2.39
- Today's Volume: 16.61K
- Yesterday Close: $2.462
- Yesterday High: $2.5
- Yesterday Low: $2.46
- Yesterday Volume: 16.95K
- Last Min Volume: 0
- Last Min High: $2.405
- Last Min Low: $2.392
- Last Min VWAP: $0
Company Profile
- Name: Neuraxis, Inc.
- Website: http://www.neuraxis.com
- Listed Date: 2023-08-09
- Location: CARMEL, IN
- Market Status: Active
- CIK Number: 0001933567
- SIC Code: 3845
- SIC description: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
- Market Cap: $23.99M
- Round Lot: 100
- Outstanding Shares: 9.87M
- Asset Type: CS
RECENT FILINGS FOR NRXS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-02 | 8-K | View |
| 2025-08-29 | 424B5 | View |
| 2025-08-12 | 10-Q | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 8-K | View |
| 2025-07-03 | 4 | View |
| 2025-07-02 | SCHEDULE 13G/A | View |
| 2025-07-01 | SCHEDULE 13G/A | View |
| 2025-06-04 | 8-K | View |
| 2025-05-28 | 8-K | View |
| 2025-05-22 | 8-K | View |
| 2025-05-22 | 424B5 | View |
| 2025-05-21 | 8-K | View |
| 2025-05-12 | 10-Q | View |
| 2025-04-23 | 4 | View |
| 2025-04-14 | DEFA14A | View |
| 2025-04-14 | DEF 14A | View |
| 2025-04-04 | ARS | View |
| 2025-04-04 | PRE 14A | View |
| 2025-03-20 | 10-K | View |
Latest News on NRXS